Target-D: a stratified individually randomized controlled trial of the diamond clinical prediction tool to triage and target treatment for depressive symptoms in general practice: study protocol for a randomized controlled trial
Authors:
- Jane GunnJGJane Gunn
- Caroline WachtlerCWCaroline Wachtler
- Susan FletcherSFSusan Fletcher
- Sandra DavidsonSDSandra Davidson
- Cathrine MihalopoulosCMCathrine Mihalopoulos
- Victoria PalmerVPVictoria Palmer
- Kelsey HegartyKHKelsey Hegarty
- Amy CoeACAmy Coe
- Elizabeth MurrayEMElizabeth Murray
- Christopher DowrickCDChristopher Dowrick
- Gavin AndrewsGAGavin Andrews
- Patty ChondrosPCPatty Chondros
Open Access
- 20 July 2017
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 18 (1) , 1-14
Abstract
Depression is a highly prevalent and costly disorder. Effective treatments are available but are not always delivered to the right person at the right time, with both under- and over-treatment a problem. Up to half the patients presenting to general practice report symptoms of depression, but general practitioners have no systematic way of efficiently identifying level of need and allocating treatment accordingly. Therefore, our team developed a new clinical prediction tool (CPT) to assist with this task. The CPT predicts depressive symptom severity in three months’ time and based on these scores classifies individuals into three groups (minimal/mild, moderate, severe), then provides a matched treatment recommendation. This study aims to test whether using the CPT reduces depressive symptoms at three months compared with usual care. The Target-D study is an individually randomized controlled trial. Participants will be 1320 general practice patients with depressive symptoms who will be approached in the practice waiting room by a research assistant and invited to complete eligibility screening on an iPad. Eligible patients will provide informed consent and complete the CPT on a purpose-built website. A computer-generated allocation sequence stratified by practice and depressive symptom severity group, will randomly assign participants to intervention (treatment recommendation matched to predicted depressive symptom severity group) or comparison (usual care plus Target-D attention control) arms. Follow-up assessments will be completed online at three and 12 months. The primary outcome is depressive symptom severity at three months. Secondary outcomes include anxiety, mental health self-efficacy, quality of life, and cost-effectiveness. Intention-to-treat analyses will test for differences in outcome means between study arms overall and by depressive symptom severity group. To our knowledge, this is the first depressive symptom stratification tool designed for primary care which takes a prognosis-based approach to provide a tailored treatment recommendation. If shown to be effective, this tool could be used to assist general practitioners to implement stepped mental-healthcare models and contribute to a more efficient and effective mental health system. Australian New Zealand Clinical Trials Registry (ANZCTR 12616000537459 ). Retrospectively registered on 27 April 2016. See Additional file 1 for trial registration data.Keywords
Funding Information
- National Health and Medical Research Council (1059863)
This publication has 72 references indexed in Scilit:
- Erratum to: changes in the lifetime prevalence of suicidal feelings and thoughts among Norwegian doctors from 2000 to 2010: a longitudinal study based on national samplesBMC Psychiatry, 2014
- Including all individuals is not enough: Lessons for intention-to-treat analysisClinical Trials, 2012
- Chronic and Recurrent Depression in Primary Care: Socio-Demographic Features, Morbidity, and CostsInternational Journal of Family Medicine, 2012
- Collaborative Care to Improve the Management of Depressive DisordersAmerican Journal of Preventive Medicine, 2012
- Framework for the impact analysis and implementation of Clinical Prediction Rules (CPRs)BMC Medical Informatics and Decision Making, 2011
- Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trialThe Lancet, 2011
- The natural course and outcome of major depressive disorder in primary care: the PREDICT-NL studySocial Psychiatry and Psychiatric Epidemiology, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- The PHQ-9Journal of General Internal Medicine, 2001